Viemed (VMD) CEO logs RSU vesting, tax withholding and share moves

Rhea-AI Filing Summary

Viemed Healthcare, Inc. Chief Executive Officer and director Hoyt Casey reported equity compensation activity and related share movements. On January 21, 2026, 49,597 Restricted Stock Units and 12,400 phantom share units vested, each unit representing the economic equivalent of one common share. In connection with the RSU vesting, the company withheld 13,565 common shares at $7.49 per share to satisfy tax obligations, and 12,400 common shares tied to phantom units were delivered back to the company for cash settlement.

After these transactions, Casey directly holds 324,582 common shares, along with 99,194 RSUs and 24,798 phantom share units. He also has an indirect holding of 1,984,943 common shares through Elizabeth Rose Homes LLC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoyt Casey

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/21/2026		M		49,597	A	(1)	338,147	D
Common Shares	01/21/2026		F		13,565(2)	D	$7.49(3)	324,582	D
Common Shares	01/21/2026		M		12,400	A	(4)	336,982	D
Common Shares	01/21/2026		D		12,400	D	$7.49(3)	324,582	D
Common Shares								1,984,943	I	by Elizabeth Rose Homes LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/21/2026		M			49,597	(5)	01/21/2028	Common Shares	49,597	$0	99,194	D
Phantom Share Units	(4)	01/21/2026		M			12,400	(6)	01/21/2028	Common Shares	12,400	(4)	24,798	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 21, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Viemed Healthcare (VMD) report for Hoyt Casey?

The filing shows that Hoyt Casey, Chief Executive Officer and director of Viemed Healthcare, Inc., reported vesting of Restricted Stock Units and phantom share units on January 21, 2026, along with related share withholding and dispositions.

How many Viemed Healthcare RSUs vested for CEO Hoyt Casey in this Form 4?

The report shows 49,597 Restricted Stock Units vested, each RSU representing a contingent right to receive one common share. These RSUs were originally granted on January 21, 2025 and vest in three equal annual installments.

Why were 13,565 Viemed Healthcare common shares withheld at $7.49?

The filing states that 13,565 common shares were withheld by the issuer at $7.49 per share to satisfy Hoyt Casey's tax obligation arising from the vesting of restricted stock units. The per-share value is based on the market closing price of the common shares for January 21, 2026.

What happened with Hoyt Casey’s phantom share units at Viemed Healthcare?

An award of 12,400 phantom share units vested under the issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one common share. The settlement is reported as a disposition of phantom shares in exchange for acquiring the underlying common shares and a simultaneous disposition of those common shares back to the company for cash.

How many Viemed Healthcare common shares does Hoyt Casey hold after these transactions?

Following the reported transactions, Hoyt Casey directly holds 324,582 common shares, plus 99,194 RSUs and 24,798 phantom share units. He also has an indirect holding of 1,984,943 common shares through Elizabeth Rose Homes LLC.

Are Hoyt Casey’s Viemed Healthcare transactions mainly compensation-related?

The activities disclosed are described as vestings of Restricted Stock Units and phantom share units granted under company plans, along with share withholding for taxes and cash settlement of phantom units. These patterns are consistent with equity-based compensation rather than open-market trading.